HYDROGEL STENT AND EMBOLIZATION DEVICE FOR CEREBRAL ANEURYSM

    公开(公告)号:US20230017150A1

    公开(公告)日:2023-01-19

    申请号:US17812892

    申请日:2022-07-15

    Abstract: A hydrogel stent for cerebral aneurysm includes a hydrogel polymer, and a stent body wrapping at least a portion of the hydrogel polymer. The stent body is expandable in a cerebral aneurysm of a blood vessel. The stent body is provided in a mesh type surrounding at least a portion of the hydrogel polymers. An embolization device for cerebral aneurysm, includes a hydrogel stent for cerebral aneurysm; a micro-conduit providing a movement path for guiding the hydrogel stent to a cerebral aneurysm of a blood vessel; and a pusher wire connected to the hydrogel stent to be movable in the movement path.

    URINARY EXOSOME BIOMARKER FOR DIAGNOSING ANTIBODY-MEDIATED REJECTION AFTER KIDNEY TRANSPLANTATION OR PREDICTING PROGNOSIS OF PATIENT AFTER KIDNEY TRANSPLANTATION

    公开(公告)号:US20220252608A1

    公开(公告)日:2022-08-11

    申请号:US17621451

    申请日:2020-06-22

    Inventor: Sung SHIN

    Abstract: The present invention relates to a biomarker for the non-invasive diagnosis of kidney transplantation rejection and use thereof, and particularly to: a biomarker composition and kit for diagnosing antibody-mediated rejection after kidney transplantation or predicting the prognosis of a patient after kidney transplantation, comprising any one or more proteins selected from the group consisting of LBP and CST3, or gene(s) encoding for the same; a method for providing information required for diagnosing antibody-mediated rejection after kidney transplantation or predicting the prognosis of a patient after kidney transplantation, by using the marker composition; a method for providing information required for determining a therapy for rejection after kidney transplantation; a method for the diagnosis and treatment of antibody-mediated rejection after kidney transplantation; and a method for screening for a therapeutic agent for antibody-mediated rejection after kidney transplantation.

    BIOMARKER CEREBLON FOR DIAGNOSING HEPATOCELLULAR CARCINOMA, AND NOVEL MONOCLONAL ANTIBODY SPECIFIC THERETO

    公开(公告)号:US20220178929A1

    公开(公告)日:2022-06-09

    申请号:US17441386

    申请日:2020-03-23

    Abstract: Provided are the use of cereblon (CRBN) as a biomarker for diagnosis of hepatocellular carcinoma and novel monoclonal antibodies specific to CRBN. More specifically, provided are a composition and a kit for diagnosing or predicting the prognosis of hepatocellular carcinoma by using CRBN as a biomarker for diagnosis of hepatocellular carcinoma, an information providing method for diagnosing or predicting the prognosis of hepatocellular carcinoma, two novel monoclonal antibodies binding specifically to CRBN, and hybridoma cells producing the same. The expression level difference of CRBN protein allows patients with hepatocellular carcinoma to be diagnosed early and indicates better predictive capabilities than the presence or absence of microvascular invasion, which was an important factor in predicting a prognosis of hepatocellular carcinoma in prior art, and thus can be expected to be used as a diagnostic marker to diagnose hepatocellular carcinoma and to evaluate a prognosis after hepatic resection.

    Catheter delivery device
    17.
    发明授权

    公开(公告)号:US11185666B2

    公开(公告)日:2021-11-30

    申请号:US16530167

    申请日:2019-08-02

    Abstract: A catheter delivery device having an improved mechanism for inserting a catheter into a blood vessel of a patient. The catheter delivery device includes at least: a body including a delivery path of a catheter; a pair of feeders having grippers located on the delivery path of the body and are configured to grip and release the catheter; and a rotator configured to rotate the catheter gripped by the feeders. The feeders move from a grip position where the grippers grip the catheter to a forward position where the grippers advance in a state of gripping the catheter, from the forward position to a grip release position where the grippers release the catheter, from the grip release position to a backward position where the grippers retract in a state of releasing a grip on the catheter, and from the backward position to the grip position.

Patent Agency Ranking